Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 19-Nov-24 4:31 PM View:  | X4 Pharmaceuticals, Inc (XFOR) | 15-Nov-24 | Sale (Planned) | 31,897 | $0.39 | $12,583.40 | (3%) 1.03M to 993.92K | |
| 16-Oct-24 4:54 PM View: | X4 Pharmaceuticals, Inc (XFOR) | 15-Oct-24 | Sale (Planned) | 31,897 | $0.56 | $17,926.10 | (3%) 1.06M to 1.03M | |
| 08-Oct-24 4:44 PM View: | X4 Pharmaceuticals, Inc (XFOR) | 07-Oct-24 | Sale (Planned) | 239,436 | $0.55 | $131,522.00 | (18%) 1.3M to 1.06M | |
| 08-Oct-24 4:44 PM View: | X4 Pharmaceuticals, Inc (XFOR) | 04-Oct-24 | Grant | 532,081 | -- | -- | 70% 765.07K to 1.3M | |
| 11-Mar-24 5:20 PM View: | X4 Pharmaceuticals, Inc (XFOR) | 11-Mar-24 | Sale | 49,678 | $0.88 | $43,855.70 | (6%) 814.75K to 765.07K | |
| 12-Feb-24 5:05 PM View: | X4 Pharmaceuticals, Inc (XFOR) | 12-Feb-24 | Sale (Planned) | 21,695 | $1.01 | $21,892.40 | (3%) 836.44K to 814.75K | |
| 03-Nov-23 5:26 PM View: | X4 Pharmaceuticals, Inc (XFOR) | 03-Nov-23 | Sale (Planned) | 39,906 | $0.90 | $35,915.40 | (5%) 876.35K to 836.44K | |
| 03-Nov-23 5:26 PM View: | X4 Pharmaceuticals, Inc (XFOR) | 01-Nov-23 | Sale (Planned) | 199,531 | $0.73 | $145,658.00 | (19%) 1.08M to 876.35K | |
| 02-Nov-23 4:58 PM View: | X4 Pharmaceuticals, Inc (XFOR) | 31-Oct-23 | Grant | 532,081 | -- | -- | 98% 543.8K to 1.08M | |
| 26-Jun-23 4:11 PM View: | X4 Pharmaceuticals, Inc (XFOR) | 23-Jun-23 | Market Sale (Planned) | 6,724 | $1.92 | $12,910.10 | (1%) 550.52K to 543.8K | (10%) |
| 16-Jun-23 4:15 PM View: | X4 Pharmaceuticals, Inc (XFOR) | 15-Jun-23 | Market Sale | 6,724 | $2.23 | $14,994.50 | (1%) 557.25K to 550.52K | 5% |
| 31-May-23 5:05 PM View: | X4 Pharmaceuticals, Inc (XFOR) | 31-May-23 | Market Sale | 6,292 | $1.95 | $12,269.40 | (1%) 563.54K to 557.25K | (9%) |
| 13-Mar-23 4:46 PM View: | X4 Pharmaceuticals, Inc (XFOR) | 10-Mar-23 | Sale | 49,678 | $0.84 | $41,729.50 | (8%) 613.22K to 563.54K | |
| 15-Feb-23 5:11 PM View: | X4 Pharmaceuticals, Inc (XFOR) | 13-Feb-23 | Sale | 21,695 | $0.93 | $20,176.30 | (3%) 634.91K to 613.22K | |
| 19-Aug-22 1:05 PM View: | X4 Pharmaceuticals, Inc (XFOR) | 17-Aug-22 | Sale (Planned) | 13,448 | -- | -- | (2%) 648.36K to 634.91K | |
| 27-Jun-22 4:09 PM View: | X4 Pharmaceuticals, Inc (XFOR) | 24-Jun-22 | Sale (Planned) | 6,724 | -- | -- | (1%) 655.08K to 648.36K | |
| 17-Jun-22 4:22 PM View: | X4 Pharmaceuticals, Inc (XFOR) | 16-Jun-22 | Sale | 6,724 | -- | -- | (1%) 661.81K to 655.08K | |
| 06-Jun-22 4:14 PM View: | X4 Pharmaceuticals, Inc (XFOR) | 03-Jun-22 | Sale (Planned) | 6,292 | $1.21 | $7,613.32 | (< 1%) 668.1K to 661.81K | |
| 01-Mar-22 4:16 PM View: | X4 Pharmaceuticals, Inc (XFOR) | 01-Mar-22 | Grant | 220,789 | -- | -- | 49% 447.31K to 668.1K | |
| 14-Feb-22 4:20 PM View: | X4 Pharmaceuticals, Inc (XFOR) | 11-Feb-22 | Sale (Planned) | 21,695 | -- | -- | (5%) 469.0K to 447.31K | |
| 19-Aug-21 4:26 PM View: | X4 Pharmaceuticals, Inc (XFOR) | 17-Aug-21 | Market Sale (Planned) | 13,448 | $5.10 | $68,584.80 | (3%) 482.45K to 469.0K | 4% |
| 16-Jul-21 4:01 PM View: | X4 Pharmaceuticals, Inc (XFOR) | 15-Jul-21 | Market Sale (Planned) | 13,448 | $5.78 | $77,729.40 | (3%) 495.9K to 482.45K | (2%) |
| 25-Jun-21 4:03 PM View: | X4 Pharmaceuticals, Inc (XFOR) | 23-Jun-21 | Grant | 44,826 | -- | -- | 10% 451.07K to 495.9K | |
| 17-Jun-21 5:12 PM View: | X4 Pharmaceuticals, Inc (XFOR) | 15-Jun-21 | Grant | 44,826 | -- | -- | 11% 406.25K to 451.07K | |
| 02-Jun-21 4:51 PM View: | X4 Pharmaceuticals, Inc (XFOR) | 02-Jun-21 | Market Sale (Planned) | 2,400 | $9.50 | $22,800.00 | (< 1%) 408.65K to 406.25K | 0% |
| 02-Jun-21 4:13 PM View: | X4 Pharmaceuticals, Inc (XFOR) | 01-Jun-21 | Market Sale (Planned) | 4,104 | $9.41 | $38,618.60 | (< 1%) 412.75K to 408.65K | (< 1%) |
| 04-May-21 4:11 PM View: | X4 Pharmaceuticals, Inc (XFOR) | 03-May-21 | Market Sale (Planned) | 2,400 | $8.33 | $19,992.00 | (< 1%) 415.15K to 412.75K | (< 1%) |
| 07-Apr-21 9:20 AM View: | X4 Pharmaceuticals, Inc (XFOR) | 05-Apr-21 | Market Sale (Planned) | 2,400 | $9.17 | $22,008.00 | (< 1%) 417.55K to 415.15K | 2% |
| 25-Mar-21 4:55 PM View: | X4 Pharmaceuticals, Inc (XFOR) | 24-Mar-21 | Grant | 144,629 | -- | -- | 53% 272.92K to 417.55K | |
| 02-Mar-21 7:05 PM View: | X4 Pharmaceuticals, Inc (XFOR) | 02-Mar-21 | Market Sale (Planned) | 2,400 | $9.74 | $23,376.00 | (< 1%) 275.32K to 272.92K | (2%) |
| 03-Feb-21 5:10 PM View: | X4 Pharmaceuticals, Inc (XFOR) | 02-Feb-21 | Market Sale (Planned) | 2,400 | $7.88 | $18,912.00 | (< 1%) 277.72K to 275.32K | (< 1%) |
| 06-Jan-21 8:25 AM View: | X4 Pharmaceuticals, Inc (XFOR) | 05-Jan-21 | Market Sale (Planned) | 2,400 | $7.00 | $16,800.00 | (< 1%) 280.12K to 277.72K | 2% |
| 28-Dec-20 4:27 PM View: | X4 Pharmaceuticals, Inc (XFOR) | 23-Dec-20 | Market Sale (Planned) | 4,800 | $7.00 | $33,600.00 | (2%) 284.92K to 280.12K | 8% |
| 06-Oct-20 8:53 AM View: | X4 Pharmaceuticals, Inc (XFOR) | 05-Oct-20 | Market Sale | 1,797 | $7.00 | $12,579.00 | (< 1%) 286.72K to 284.92K | 8% |
| 05-Oct-20 4:38 PM View: | X4 Pharmaceuticals, Inc (XFOR) | 02-Oct-20 | Market Sale | 603 | $7.00 | $4,221.00 | (< 1%) 287.32K to 286.72K | 8% |
| 10-Sep-20 8:35 AM View: | X4 Pharmaceuticals, Inc (XFOR) | 09-Sep-20 | Market Sale (Planned) | 8,840 | $8.04 | $71,073.60 | (3%) 296.16K to 287.32K | 20% |
| 03-Sep-20 5:15 PM View: | X4 Pharmaceuticals, Inc (XFOR) | 02-Sep-20 | Market Sale (Planned) | 2,400 | $7.99 | $19,176.00 | (< 1%) 298.56K to 296.16K | 19% |
| 18-Aug-20 8:12 PM View: | X4 Pharmaceuticals, Inc (XFOR) | 17-Aug-20 | Grant | 44,825 | -- | -- | 18% 253.74K to 298.56K | |
| 18-Aug-20 8:12 PM View: | X4 Pharmaceuticals, Inc (XFOR) | 14-Aug-20 | Grant | 44,826 | -- | -- | 21% 208.91K to 253.74K | |
| 04-Aug-20 4:33 PM View: | X4 Pharmaceuticals, Inc (XFOR) | 03-Aug-20 | Market Sale (Planned) | 2,400 | $7.45 | $17,880.00 | (1%) 211.31K to 208.91K | 14% |
| 06-Jul-20 4:24 PM View: | X4 Pharmaceuticals, Inc (XFOR) | 02-Jul-20 | Market Sale (Planned) | 2,400 | $9.05 | $21,720.00 | (1%) 213.71K to 211.31K | 29% |
| 03-Jun-20 4:46 PM View: | X4 Pharmaceuticals, Inc (XFOR) | 03-Jun-20 | Market Sale (Planned) | 9,707 | $8.88 | $86,198.20 | (4%) 223.42K to 213.71K | 28% |
| 03-Jun-20 4:46 PM View: | X4 Pharmaceuticals, Inc (XFOR) | 02-Jun-20 | Market Sale (Planned) | 2,400 | $8.65 | $20,760.00 | (1%) 225.82K to 223.42K | 26% |
| 03-Jun-20 4:46 PM View: | X4 Pharmaceuticals, Inc (XFOR) | 01-Jun-20 | Market Sale (Planned) | 4,275 | $8.63 | $36,893.20 | (2%) 230.09K to 225.82K | 25% |
| 05-May-20 5:25 PM View: | X4 Pharmaceuticals, Inc (XFOR) | 04-May-20 | Market Sale (Planned) | 2,400 | $8.92 | $21,408.00 | (1%) 232.49K to 230.09K | 28% |
| 03-Apr-20 3:59 PM View: | X4 Pharmaceuticals, Inc (XFOR) | 02-Apr-20 | Market Sale (Planned) | 2,400 | $8.40 | $20,160.00 | (1%) 234.89K to 232.49K | 23% |
| 03-Mar-20 4:59 PM View: | X4 Pharmaceuticals, Inc (XFOR) | 02-Mar-20 | Market Sale (Planned) | 2,400 | $10.64 | $25,536.00 | (1%) 237.29K to 234.89K | 40% |
| 19-Jun-19 4:15 PM View: | X4 Pharmaceuticals, Inc (XFOR) | 17-Jun-19 | Grant | 55,928 | -- | -- | 31% 181.37K to 237.29K | |
| 14-Mar-19 9:25 PM View: | X4 Pharmaceuticals, Inc (XFOR) | 13-Mar-19 | Grant | 181,366 | -- | -- | 100% 0 to 181.37K |